The possible role of neuromedin U (NMU) or GABA type A receptor subunit alpha-5 (GABRA5) in NB progression was not previously described, but there are reports that NMU is overexpressed and involved in the progression of pancreatic, breast, and endometrial cancers (54–56). Here, NMU is linked to endometrial cancer.